TB-500 Maintenance Protocol for Dogs — What It Means

A TB-500 maintenance protocol for dogs is the lower-intensity phase owners move into after a more concentrated recovery block — the same peptide support, continued at a reduced cadence, to keep backing tissue that has come through the hardest part of repair but still carries load every single day. It is a plan, not a different product. It answers three questions: how often, for how long, and what sits alongside it. Every one of those answers belongs to your veterinarian, who knows the diagnosis, the imaging, the medications your dog is already taking and how the limb behaves under real load. TB-500 and BPC-157 are not FDA-approved veterinary drugs, and nothing on this page is a dosing schedule.

K9-REPAIR from pawgen is the BPC-157 and TB-500 formulation many owners run through recovery and then carry forward into maintenance, precisely because the same two peptides are involved in both phases. What changes between recovery and maintenance is the intensity and the surrounding plan — not the ingredients.

Why tissue keeps changing long after the limp disappears

The reason a maintenance phase exists at all is that soft tissue repair does not finish when the visible problem stops being visible.

Repair moves through overlapping stages. First there is an inflammatory response, which clears damaged material and recruits cells to the site. Then a proliferative stage lays down new matrix quickly — the biological equivalent of a rough patch, mostly disorganised type III collagen, strong enough to hold things together but not aligned for the forces the structure actually has to handle. Only in the remodelling stage does that patch get progressively reorganised: type III collagen is gradually replaced with type I, fibres reorient along the lines of stress the limb experiences, and cross-linking increases.

That last stage is the slow one, and it is the reason a dog can look completely sound while the tissue underneath is still mechanically immature. Tendon and ligament are poorly vascularised compared with muscle, which is exactly why they are slow to repair and slow to remodel. Cartilage is worse still. The dog's own behaviour makes this harder to read, because dogs are efficient at masking discomfort by redistributing load to other limbs — so gait can normalise to the human eye long before the healing structure is genuinely ready for hard cornering, stairs and jumping off furniture.

Maintenance is not a smaller version of recovery — it is a deliberate decision about how much support a structure still needs during the long remodelling window, after the obvious signs have already resolved.

What TB-500 and BPC-157 are actually doing

TB-500 is a synthetic peptide based on the active region of thymosin beta-4, a naturally occurring protein found throughout the body and present in high concentrations at sites of tissue injury. Thymosin beta-4's best-characterised job is binding actin, the protein cells use to build their internal scaffolding and to move. Published research, largely in laboratory and animal models, associates it with cell migration, the formation of new blood vessels and the regulation of inflammatory signalling. Framed practically: research suggests it acts on the logistics of repair — getting the right cells to the right place and improving the blood supply that any slow-healing structure depends on.

BPC-157 is a pentadecapeptide — a short fifteen-amino-acid sequence — derived from a protein identified in gastric juice. Research in animal and cell models has focused on tendon, ligament and gut tissue, and on angiogenic signalling pathways, with reported effects on the outgrowth and migration of tendon fibroblasts, the cells that manufacture collagen. Early evidence indicates the two peptides work on complementary parts of the same problem, which is why they are so commonly used together rather than separately.

That complementarity is the logic behind a combined stack, and it is why owners tend not to drop one peptide when they move into maintenance. The remodelling stage is still fundamentally a collagen-quality and blood-supply problem. Owners report continuing peptide support through that window for the same reason they started it — the underlying biology has not finished. None of this constitutes a promise about your dog's outcome, and none of it replaces a diagnosis.

Moving from a recovery block into maintenance

The trigger for the switch should be functional, not a date on the calendar. The useful questions are behavioural and mechanical: how does the dog rise from lying down after a long rest, how does it load the limb at a slow trot, how does it sit, how does it manage a controlled descent on stairs. Your veterinarian or a rehabilitation professional can assess this properly, including things an owner genuinely cannot see, such as subtle muscle asymmetry, joint range of motion and pain on manipulation.

One principle is worth internalising: remodelling responds to mechanical load. Collagen aligns along the lines of stress it experiences, which means controlled, progressive loading is not just permitted during maintenance — it is the stimulus that shapes the repair. That is also why the transition should be handled as one change at a time. If you reduce peptide frequency and simultaneously double the walk distance and reintroduce ball chasing, you have no way to interpret a setback.

Keep a simple log. Date, distance, surface, and one or two behavioural markers — willingness to jump onto the couch, stiffness on rising, how the dog looks the morning after a bigger day. This is boring and it is the single most useful thing an owner contributes to the plan, because it converts vague impressions into a record your vet can actually work from at the recheck.

What belongs in a maintenance plan

Peptide support is one element among several. A maintenance phase that consists only of a supplement is not a plan.

Element	What it contributes	Who owns the decision
Veterinary reassessment	Confirms the structure is progressing and catches compensatory problems in the other limbs	Your veterinarian
Prescribed medication	Pain and inflammation control that makes controlled loading possible	Your veterinarian — never adjusted or stopped independently
Progressive loading and rehab	The mechanical stimulus that aligns remodelling collagen	Vet or rehab professional, executed by you
Body condition	Every excess kilogram is load applied to the healing structure on every single step	Vet-guided, owner-executed
Traction and home setup	Runners on hard floors, ramps off furniture, trimmed nails and paw hair — removes the slips that undo weeks of progress	Owner
Peptide support (K9-REPAIR)	BPC-157 and TB-500 in a dog-specific, weight-based formulation, third-party tested with COAs available	Owner, in consultation with the vet

This is also where healthy skepticism belongs — pointed at the shelf, not at the science. A large share of joint products sold to worried owners are multi-ingredient chews built around proprietary blends, where the label lists twelve impressive-sounding ingredients without disclosing how much of any single one is present. Frequently the answer is: not much. A blend disclosure that hides individual quantities is a formulation decision, and it is usually made for cost reasons rather than biological ones. What you want instead is a short ingredient list, quantities you can actually see, dosing scaled to body weight rather than one-size-fits-all, and third-party certificates of analysis you can request. pawgen ships K9-REPAIR direct to the door and backs it with a 60-day money-back guarantee, which is the kind of commitment a brand only makes when it expects owners to keep using the product.

Why there is no dose number on this page

Because there is no number that is correct for every dog, and publishing one would be irresponsible. Peptide amounts are scaled to body weight, but weight is only the starting point. The stage of repair matters. The structure involved matters — a partial tendon injury and post-operative stifle stabilisation are not the same job. Concurrent medications matter. Life stage matters enormously, and dosing for puppies, pregnant dogs and nursing dogs is a conversation for your veterinarian only, never a figure taken from an article.

So the honest answer to every dosing question — starting amount, maintenance frequency, whether to split administration, when to step down, when to stop — is that you should work it out with your veterinarian, who can also tell you how peptide support fits around anything already prescribed. Talk to your veterinarian before you begin, and again before you change the cadence.

Signals that the plan needs another look

Maintenance is not passive. The behaviours worth flagging at a recheck are the small ones: hesitating at the couch or the car boot, taking stairs one at a time, slipping on hard floors more than usual, sitting with a hind leg kicked out to the side, licking persistently at one joint, lagging on the back half of a walk, or being noticeably stiff the morning after activity.

Any of these can mean the loading programme has moved faster than the tissue, that a compensating limb is now the problem, or that something new is going on. None of them are things to interpret alone.

Key Takeaways

• A maintenance protocol is a reduced-intensity continuation of peptide support during the long remodelling window, not a different product.
• Remodelling continues well after the limp resolves, because collagen reorganisation in poorly vascularised tissue is slow.
• Research suggests TB-500 acts on cell migration and blood vessel formation, while BPC-157 research has focused on tendon fibroblast behaviour and angiogenic signalling — complementary jobs.
• Change one variable at a time when stepping down, and log what you see.
• Amounts, frequency and duration are veterinary decisions; life-stage cases go to the vet without exception.
• BPC-157 and TB-500 are not FDA-approved veterinary drugs, and this is educational content.

If you are working out how to structure administration around your dog's day, two related pieces go deeper: the wolverine stack morning vs evening for dogs and the wolverine stack splitting doses for dogs, and the formulation itself is K9-REPAIR.

Your veterinarian owns the diagnosis and the treatment plan. Surgery, prescribed medication and a structured rehabilitation programme are what create a healing environment in the first place, and nothing described here belongs in front of them or in place of them. Peptides operate in the space that proper veterinary care creates — as support during a long remodelling process, chosen by owners who want to back the work their vet has already set in motion.

Owners exploring peptide support for their dog can review K9-REPAIR — BPC-157 + TB-500 formulated for dogs — at https://pawgen.com/. BPC-157 and TB-500 are not FDA-approved veterinary drugs. Nothing in this article treats, cures or prevents any condition; every decision about your dog's care belongs with your veterinarian.